📊 NTHI Key Takeaways
Is Neonc Technologies Holdings, Inc.. (NTHI) a Good Investment?
NTHI exhibits critical financial distress with negative stockholders' equity of -$13.2M, technical insolvency, and a severe liquidity crisis (current ratio 0.13x). The company generates negligible revenue ($40K, down 51.8% YoY) while sustaining massive operating losses ($7.1M), resulting in negative free cash flow of -$7.5M and inadequate cash reserves ($138.6K). For a pharmaceutical company, the absence of meaningful revenue indicates no viable commercialized products, combined with mounting liabilities that exceed total assets by $13.3M.
NTHI exhibits negligible revenue alongside extremely large operating losses, negative equity, and near-zero cash, indicating acute financial distress. Liquidity metrics (0.07x current ratio) and substantial cash burn point to an urgent need for external financing and elevated going‑concern risk. Without clear revenue traction or a materially reduced burn rate, the fundamentals remain unattractive.
Why Buy Neonc Technologies Holdings, Inc.. Stock? NTHI Key Strengths
- Minimal cash position provides short-term buffer
- Active insider activity indicates potential strategic engagement
- Nasdaq listing provides access to capital markets if restructuring pursued
- Low long-term debt outstanding
- Potential upside from R&D pipeline/IP if successful
- Public listing can facilitate capital raises
NTHI Stock Risks: Neonc Technologies Holdings, Inc.. Investment Risks
- Negative stockholders' equity of -$13.2M represents technical insolvency
- Current ratio of 0.13x signals acute liquidity crisis with liabilities 7.7x current assets
- Operating cash burn of -$7.0M per period with only $138.6K cash on hand
- Revenue collapse of 51.8% YoY with $40K quarterly revenue insufficient to support operations
- Total liabilities of $16.6M exceed total assets by $13.3M, indicating debt service capacity crisis
- No identifiable product revenue in pharmaceutical sector suggests absent commercialization strategy
- Liquidity crisis with minimal cash and 0.07x current ratio
- Negative stockholders' equity and unfavorable financing/delisting risk
- Sustained large operating losses and declining revenue
Key Metrics to Watch
- Cash depletion timeline and whether operations cease within 2-3 months
- Restructuring or going-concern announcements in SEC filings
- Changes in revenue traction and operating cash burn rate
- Insider trading patterns and management retention
- Debt covenant compliance status and refinancing ability
- Cash & equivalents vs quarterly operating cash burn (runway)
- Current ratio and net working capital
Neonc Technologies Holdings, Inc.. (NTHI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NTHI Profit Margin, ROE & Profitability Analysis
NTHI vs Healthcare Sector: How Neonc Technologies Holdings, Inc.. Compares
How Neonc Technologies Holdings, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Neonc Technologies Holdings, Inc.. Stock Overvalued? NTHI Valuation Analysis 2026
Based on fundamental analysis, Neonc Technologies Holdings, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Neonc Technologies Holdings, Inc.. Balance Sheet: NTHI Debt, Cash & Liquidity
NTHI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Neonc Technologies Holdings, Inc..'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.69 indicates the company is currently unprofitable.
NTHI Revenue Growth, EPS Growth & YoY Performance
NTHI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $40.0K | -$8.8M | $-0.38 |
| Q3 2025 | $40.0K | -$2.2M | $-0.12 |
| Q2 2025 | $20.0K | -$4.5M | $-0.27 |
| Q1 2025 | $40.0K | -$2.9M | $-0.18 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Neonc Technologies Holdings, Inc.. Dividends, Buybacks & Capital Allocation
NTHI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Neonc Technologies Holdings, Inc.. (CIK: 0001979414)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NTHI
What is the AI rating for NTHI?
Neonc Technologies Holdings, Inc.. (NTHI) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 93% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NTHI's key strengths?
Claude: Minimal cash position provides short-term buffer. Active insider activity indicates potential strategic engagement. ChatGPT: Low long-term debt outstanding. Potential upside from R&D pipeline/IP if successful.
What are the risks of investing in NTHI?
Claude: Negative stockholders' equity of -$13.2M represents technical insolvency. Current ratio of 0.13x signals acute liquidity crisis with liabilities 7.7x current assets. ChatGPT: Liquidity crisis with minimal cash and 0.07x current ratio. Negative stockholders' equity and unfavorable financing/delisting risk.
What is NTHI's revenue and growth?
Neonc Technologies Holdings, Inc.. reported revenue of $40.0K.
Does NTHI pay dividends?
Neonc Technologies Holdings, Inc.. does not currently pay dividends.
Where can I find NTHI SEC filings?
Official SEC filings for Neonc Technologies Holdings, Inc.. (CIK: 0001979414) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NTHI's EPS?
Neonc Technologies Holdings, Inc.. has a diluted EPS of $-0.38.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NTHI a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Neonc Technologies Holdings, Inc.. has a STRONG SELL rating with 93% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NTHI stock overvalued or undervalued?
Valuation metrics for NTHI: ROE of N/A (sector avg: 15%), net margin of -22,055.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NTHI stock in 2026?
Our dual AI analysis gives Neonc Technologies Holdings, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NTHI's free cash flow?
Neonc Technologies Holdings, Inc..'s operating cash flow is $-7.0M, with capital expenditures of $500.0K. FCF margin is -18,734.1%.
How does NTHI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -22,055.3% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.13 (avg: 2).